{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T19:38:56Z","timestamp":1776973136103,"version":"3.51.4"},"reference-count":61,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Objectives This article summarizes past and current data mining activities at the United States Food and Drug Administration (FDA).<\/jats:p>\n               <jats:p>Target audience We address data miners in all sectors, anyone interested in the safety of products regulated by the FDA (predominantly medical products, food, veterinary products and nutrition, and tobacco products), and those interested in FDA activities.<\/jats:p>\n               <jats:p>Scope Topics include routine and developmental data mining activities, short descriptions of mined FDA data, advantages and challenges of data mining at the FDA, and future directions of data mining at the FDA.<\/jats:p>","DOI":"10.1093\/jamia\/ocv063","type":"journal-article","created":{"date-parts":[[2015,7,25]],"date-time":"2015-07-25T01:24:05Z","timestamp":1437787445000},"page":"428-434","source":"Crossref","is-referenced-by-count":132,"title":["Use of data mining at the Food and Drug Administration"],"prefix":"10.1093","volume":"23","author":[{"given":"Hesha J","family":"Duggirala","sequence":"first","affiliation":[{"name":"Center for Veterinary Medicine, FDA"}]},{"given":"Joseph M","family":"Tonning","sequence":"additional","affiliation":[{"name":"Center for Drug Evaluation and Research, FDA"}]},{"given":"Ella","family":"Smith","sequence":"additional","affiliation":[{"name":"Center for Food Safety and Applied Nutrition, FDA"}]},{"given":"Roselie A","family":"Bright","sequence":"additional","affiliation":[{"name":"Office of the Commissioner, FDA"}]},{"given":"John D","family":"Baker","sequence":"additional","affiliation":[{"name":"Center for Veterinary Medicine, FDA"}]},{"given":"Robert","family":"Ball","sequence":"additional","affiliation":[{"name":"Center for Biologics Evaluation and Research, FDA"}]},{"given":"Carlos","family":"Bell","sequence":"additional","affiliation":[{"name":"Center for Drug Evaluation and Research, FDA"}]},{"given":"Susan J","family":"Bright-Ponte","sequence":"additional","affiliation":[{"name":"Center for Veterinary Medicine, FDA"}]},{"given":"Taxiarchis","family":"Botsis","sequence":"additional","affiliation":[{"name":"Center for Biologics Evaluation and Research, FDA"}]},{"given":"Khaled","family":"Bouri","sequence":"additional","affiliation":[{"name":"Office of the Commissioner, FDA"}]},{"given":"Marc","family":"Boyer","sequence":"additional","affiliation":[{"name":"Center for Food Safety and Applied Nutrition, FDA"}]},{"given":"Keith","family":"Burkhart","sequence":"additional","affiliation":[{"name":"Center for Drug Evaluation and Research, FDA"}]},{"given":"G","family":"Steven Condrey","sequence":"additional","affiliation":[{"name":"Office of Regulatory Affairs, FDA"}]},{"given":"James J","family":"Chen","sequence":"additional","affiliation":[{"name":"National Center for Toxicological Research, FDA"}]},{"given":"Stuart","family":"Chirtel","sequence":"additional","affiliation":[{"name":"Center for Food Safety and Applied Nutrition, FDA"}]},{"given":"Ross W","family":"Filice","sequence":"additional","affiliation":[{"name":"Office of the Commissioner, FDA"}]},{"given":"Henry","family":"Francis","sequence":"additional","affiliation":[{"name":"Center for Drug Evaluation and Research, FDA"}]},{"given":"Hongying","family":"Jiang","sequence":"additional","affiliation":[{"name":"Center for Devices and Radiological Health, FDA"}]},{"given":"Jonathan","family":"Levine","sequence":"additional","affiliation":[{"name":"Office of the Commissioner, FDA"}]},{"given":"David","family":"Martin","sequence":"additional","affiliation":[{"name":"Center for Biologics Evaluation and Research, FDA"}]},{"given":"Taiye","family":"Oladipo","sequence":"additional","affiliation":[{"name":"Center for Food Safety and Applied Nutrition, FDA"}]},{"given":"Rene","family":"O\u2019Neill","sequence":"additional","affiliation":[{"name":"Center for Devices and Radiological Health, FDA"}]},{"given":"Lee Anne M.","family":"Palmer","sequence":"additional","affiliation":[{"name":"Center for Veterinary Medicine, FDA"}]},{"given":"Antonio","family":"Paredes","sequence":"additional","affiliation":[{"name":"Center for Tobacco Products, FDA"}]},{"given":"George","family":"Rochester","sequence":"additional","affiliation":[{"name":"Center for Tobacco Products, FDA"}]},{"given":"Deborah","family":"Sholtes","sequence":"additional","affiliation":[{"name":"Center for Tobacco Products, FDA"}]},{"given":"Ana","family":"Szarfman","sequence":"additional","affiliation":[{"name":"Center for Drug Evaluation and Research, FDA"}]},{"given":"Hui-Lee","family":"Wong","sequence":"additional","affiliation":[{"name":"Center for Devices and Radiological Health, FDA"}]},{"given":"Zhiheng","family":"Xu","sequence":"additional","affiliation":[{"name":"Center for Devices and Radiological Health, FDA"}]},{"given":"Taha","family":"Kass-Hout","sequence":"additional","affiliation":[{"name":"Office of the Commissioner, FDA"}]}],"member":"286","published-online":{"date-parts":[[2015,7,23]]},"reference":[{"key":"2020110613004970500_ocv063-B1"},{"key":"2020110613004970500_ocv063-B2","article-title":"Good Pharmacovigilance Practices and Pharmacoepidemiologic Assessment","author":"Guidance for Industry","year":", 2005"},{"key":"2020110613004970500_ocv063-B3","author":"Data Mining at FDA"},{"key":"2020110613004970500_ocv063-B4","author":"FDA Organization"},{"issue":"1","key":"2020110613004970500_ocv063-B5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/pds.773","article-title":"A model for the future conduct of pharmacovigilance","volume":"12","author":"Waller","year":"2003","journal-title":"Pharnaccoepidemiol Drug Saf."},{"issue":"6","key":"2020110613004970500_ocv063-B6","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/pds.677","article-title":"Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports","volume":"10","author":"Evans","year":"2001","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"1","key":"2020110613004970500_ocv063-B7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0038-1636131","article-title":"Systemic signalling of adverse reactions to drugs","volume":"13","author":"Finney","year":"1974","journal-title":"Methods Inf Med."},{"issue":"6","key":"2020110613004970500_ocv063-B8","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/pds.1742","article-title":"Quantitative signal detection using spontaneous ADR reporting","volume":"18","author":"Bate","year":"2009","journal-title":"Pharmacoepidemiol and Drug Saf."},{"issue":"9","key":"2020110613004970500_ocv063-B9","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1592\/phco.24.13.1099.38090","article-title":"Pharmacovigilance in the 21st century: new systematic tools for an old problem","volume":"24","author":"Szarfman","year":"2004","journal-title":"Pharmacotherapy."},{"issue":"6","key":"2020110613004970500_ocv063-B10","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1136\/amiajnl-2011-000793","article-title":"Application of change point analysis to daily influenza-like illness emergency department visits","volume":"19","author":"Kass-Hout","year":"2012","journal-title":"J Am Med Inform Assoc."},{"key":"2020110613004970500_ocv063-B11","article-title":"Change point analysis","author":"Kass-Hout"},{"key":"2020110613004970500_ocv063-B12","doi-asserted-by":"crossref","first-page":"362","DOI":"10.2307\/2528096","article-title":"A method for cluster analysis","volume":"21","author":"Edwards","year":"1965","journal-title":"Biometrics."},{"issue":"1","key":"2020110613004970500_ocv063-B13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0092-8240(89)80047-3","article-title":"Algorithms for the optimal identification of segment neighborhoods","volume":"51","author":"Auger","year":"1989","journal-title":"Bull Math Biol."},{"issue":"1","key":"2020110613004970500_ocv063-B14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2307\/2998540","article-title":"Estimating and testing linear models with multiple structural changes","volume":"66","author":"Bai","year":"1998","journal-title":"Econometrica."},{"issue":"500","key":"2020110613004970500_ocv063-B15","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1080\/01621459.2012.737745","article-title":"Optimal detection of changepoints with a linear computational cost","volume":"107","author":"Killick","year":"2012","journal-title":"JASA."},{"key":"2020110613004970500_ocv063-B16","article-title":"changepoint: an R package for changepoint analysis","author":"Killick","year":"2012"},{"issue":"6","key":"2020110613004970500_ocv063-B17","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/amiajnl-2012-000881","article-title":"Vaccine adverse event text mining system for extracting features from vaccine safety reports","volume":"19","author":"Botsis","year":"2012","journal-title":"J Am Med Inform Assoc."},{"key":"2020110613004970500_ocv063-B18","first-page":"195","article-title":"Drugs highly associated with infusion reactions reported using two different data-mining methodologies","volume":"5","author":"Moore","year":"2014","journal-title":"J Blood Disorders Transf."},{"key":"2020110613004970500_ocv063-B19","author":"FDA\u2019s Geographic Information System"},{"issue":"7","key":"2020110613004970500_ocv063-B20","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1210\/jc.2009-2546","article-title":"Dissimilar hepatotoxicity profiles of propylthiouracil and methimazole in children","volume":"95","author":"Rivkees","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2020110613004970500_ocv063-B21","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1001\/archneur.63.2.299-b","article-title":"Association between pathologic gambling and Parkinsonian therapy as detected in the Food and Drug Administration Adverse Event database","volume":"63","author":"Szarfman","year":"2006","journal-title":"Arch Neurol."},{"issue":"2","key":"2020110613004970500_ocv063-B22","first-page":"271","article-title":"Can network analysis improve pattern recognition among adverse events following immunization reported to VAERS? \n              Clin Pharmacol Ther","volume":"90","author":"Ball","journal-title":"2011"},{"key":"2020110613004970500_ocv063-B23","first-page":"1178","article-title":"Novel algorithms for improved pattern recognition using the US FDA adverse event network analyzer","volume":"205","author":"Botsis","year":"2014","journal-title":"Stud Health Technol Inform."},{"issue":"11","key":"2020110613004970500_ocv063-B24","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2165\/00002018-200528110-00002","article-title":"Perspectives on the use of data mining in pharmacovigilance","volume":"28","author":"Almenoff","year":"2005","journal-title":"Drug Saf."},{"key":"2020110613004970500_ocv063-B25"},{"key":"2020110613004970500_ocv063-B26","article-title":"World Health Organization","author":"Vigibase"},{"key":"2020110613004970500_ocv063-B27","article-title":"U.S. National Library of Medicine","author":"TOXNET databases"},{"key":"2020110613004970500_ocv063-B28","article-title":"U.S. National Library of Medicine","author":"Medical terminologies at NLM"},{"key":"2020110613004970500_ocv063-B29","article-title":"U.S. National Library of Medicine","author":"DAILYMED"},{"key":"2020110613004970500_ocv063-B30","article-title":"Food and Drug Administration","author":"Welcome to Mini-Sentinel"},{"issue":"7","key":"2020110613004970500_ocv063-B31","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s40264-013-0051-9","article-title":"Data mining for prospective early detection of safety signals in the Vaccine Adverse Event Reporting System (VAERS): a case study of febrile seizures after a 2010-2011 seasonal influenza virus vaccine","volume":"36","author":"Martin","year":"2013","journal-title":"Drug Saf."},{"issue":"6","key":"2020110613004970500_ocv063-B32","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1592\/phco.26.6.748","article-title":"Atypical antipsychotics and pituitary tumors: a pharmacovigilance study","volume":"26","author":"Szarfman","year":"2006","journal-title":"Pharmacotherapy."},{"issue":"11","key":"2020110613004970500_ocv063-B33","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/pds.1643","article-title":"An evaluation of a data mining signal for amyotrophic lateral sclerosis and statins detected in FDA's spontaneous adverse event reporting system","volume":"17","author":"Colman","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"7","key":"2020110613004970500_ocv063-B34","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1038\/ajg.2010.5","article-title":"Hepatoxicity due to Hydroxycut\u00ae: a case series","volume":"105","author":"Fong","year":"2010","journal-title":"Am J Gastroenterol."},{"key":"2020110613004970500_ocv063-B35","article-title":"FDA","author":"Warning on Hydroxycut"},{"issue":"1","key":"2020110613004970500_ocv063-B36","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/pds.2261","article-title":"Disproportionality analysis for signal detection of implantable cardioverter-defibrillator-related adverse events in the Food and Drug Administration Medical Device Reporting System","volume":"21","author":"Duggirala","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"2020110613004970500_ocv063-B37","article-title":"U.S. National Library of Medicine","author":"Fact Sheet: Medical Subject Headings (MeSH\u00ae)"},{"key":"2020110613004970500_ocv063-B38","article-title":"ICH Steering Committee","author":"Welcome to MedDRA"},{"key":"2020110613004970500_ocv063-B39","article-title":"Medical Officer\u2019s Consultative Reanalysis of the Febrile Neutropenia Studies of NDA 50-679","author":"Ana"},{"issue":"4","key":"2020110613004970500_ocv063-B40","doi-asserted-by":"crossref","first-page":"515","DOI":"10.4338\/ACI-2013-04-RA-0028","article-title":"Automating case definitions using literature-based reasoning","volume":"4","author":"Botsis","year":"2013","journal-title":"Appl Clin Inform."},{"issue":"5","key":"2020110613004970500_ocv063-B41","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s40264-014-0155-x","article-title":"Digital drug safety surveillance: monitoring pharmaceutical products in twitter","volume":"37","author":"Freifeld","year":"2014","journal-title":"Drug Saf."},{"key":"2020110613004970500_ocv063-B42","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/10543409508835100","article-title":"Comparing reporting rates of adverse events between drugs with adjustment for year of marketing and secular trends in total reporting","volume":"5","author":"Tsong","year":"1995","journal-title":"J. Biopharm. Stat."},{"issue":"5","key":"2020110613004970500_ocv063-B43","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2165\/00002018-200629050-00003","article-title":"Under-reporting of adverse drug reactions: a systematic review","volume":"29","author":"Hazell","year":"2006","journal-title":"Drug Saf."},{"issue":"3","key":"2020110613004970500_ocv063-B44","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2125.1992.tb04031.x","article-title":"Measuring the frequency of adverse drug reactions","volume":"33","author":"Waller","year":"1992","journal-title":"Br J Clin Pharmac."},{"issue":"3","key":"2020110613004970500_ocv063-B45","first-page":"575","article-title":"Prospective study of the influence of the media on reporting medical events","volume":"24","author":"Meinzinger","year":"1990","journal-title":"Ther Innov Regul Sci."},{"issue":"3","key":"2020110613004970500_ocv063-B46","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/pds.1535","article-title":"Estimating the extent of reporting to FDA: a case study of statin-associated rhabdomyolysis","volume":"17","author":"McAdams","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"9458","key":"2020110613004970500_ocv063-B47","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0140-6736(05)17864-7","article-title":"Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study","volume":"365","author":"Graham","year":"2005","journal-title":"Lancet."},{"key":"2020110613004970500_ocv063-B48","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/9780470060872.ch4","article-title":"Surveillance of adverse medical device events","volume-title":"Medical Device Epidemiology and Surveillance","author":"Bright","year":"2007"},{"key":"2020110613004970500_ocv063-B49","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.ijmedinf.2006.05.046","article-title":"Technology, governance, and patient safety: Systems issues in technology and patient safety","volume":"76","author":"Balka","year":"2007","journal-title":"Int J Med Inform."},{"issue":"3","key":"2020110613004970500_ocv063-B50","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1001\/jama.291.3.325","article-title":"Surveillance of medical device-related hazards and adverse events in hospitalized patients","volume":"291","author":"Samore","year":"2004","journal-title":"JAMA."},{"key":"2020110613004970500_ocv063-B51"},{"issue":"3","key":"2020110613004970500_ocv063-B52","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.amepre.2004.04.005","article-title":"Estimates of medical device-associated adverse events from emergency departments","volume":"27","author":"Hefflin","year":"2004","journal-title":"Am J Prev Med."},{"issue":"2","key":"2020110613004970500_ocv063-B53","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/pds.684","article-title":"Automated support for pharmacovigilance: a proposed system","volume":"11","author":"Bright","year":"2002","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"2020110613004970500_ocv063-B54"},{"issue":"3","key":"2020110613004970500_ocv063-B55","doi-asserted-by":"crossref","first-page":"526","DOI":"10.2106\/00004623-200703000-00009","article-title":"Incidence and short-term outcomes of primary and revision hip replacement in the United States","volume":"89","author":"Zhan","year":"2007","journal-title":"J Bone Joint Surg Am."},{"key":"2020110613004970500_ocv063-B56","article-title":"Issue brief: patient-generated health data and health IT","author":"Deering"},{"issue":"1","key":"2020110613004970500_ocv063-B57","first-page":"170","article-title":"Transforming health care delivery through consumer engagement, health data transparency, and patient-generated health information","volume":"9","author":"Sands","year":"2014","journal-title":"Yearb Med Inform."},{"key":"2020110613004970500_ocv063-B58","article-title":"US Department of Health and Human Services","author":"HealthData.gov"},{"key":"2020110613004970500_ocv063-B59","article-title":"US Consumer Product Safety Commission","author":"National Electronic Injury Surveillance System (NEISS)"},{"issue":"7232","key":"2020110613004970500_ocv063-B60","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/nature07634","article-title":"Detecting influenza epidemics using search engine query data","volume":"457","author":"Ginsberg","year":"2009","journal-title":"Nature."},{"issue":"2","key":"2020110613004970500_ocv063-B61","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.2014.77","article-title":"Toward enhanced pharmacovigilance using patient-generated data on the internet","volume":"96","author":"White","year":"2014","journal-title":"Clin Pharmacol Ther."}],"container-title":["Journal of the American Medical Informatics Association"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jamia\/article-pdf\/23\/2\/428\/34147675\/ocv063.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jamia\/article-pdf\/23\/2\/428\/34147675\/ocv063.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T18:45:39Z","timestamp":1604688339000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jamia\/article\/23\/2\/428\/2572367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,23]]},"references-count":61,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,7,23]]},"published-print":{"date-parts":[[2016,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jamia\/ocv063","relation":{},"ISSN":["1527-974X","1067-5027"],"issn-type":[{"value":"1527-974X","type":"electronic"},{"value":"1067-5027","type":"print"}],"subject":[],"published-other":{"date-parts":[[2016,3]]},"published":{"date-parts":[[2015,7,23]]}}}